Shanghai FDA Signs Agreement With U.S. Law Firm To Foster International Cooperation on Drug Regulation

BEIJING - A new government think tank focused on health-sector regulatory reform and international cooperation set up by the Shanghai FDA will work closely with a U.S.-based law firm to review drug laws worldwide and to host a series of global exchanges

More from Archive

More from Scrip